Tradestie Institutional Equity Comparison Engine

VTAK vs TVGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TVGN Overall Edge

TVGN Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tevogen Bio Holdings Inc. Common Stock (TVGN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, VTAK trades at N/M Forward P/E with -388.1% operating margin (+380.7% YoY revenue) versus TVGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VTAK N/M vs TVGN N/M Fwd P/E
Growth & Margin Winner TVGN
Op Margin -388.1% vs 0.0% ยท YoY +380.7% vs +0.0%
Momentum & Technical Winner TVGN
1Y -94.3% vs +1198.4% ยท 52W Pos 1% vs 47%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
1M Return -24.76%
1Y Return -94.28%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0
TVGN NASDAQ
Tevogen Bio Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$5.76
-7.32% 1D
Market Cap $406.6M
1M Return -14.84%
1Y Return +1198.42%
Forward P/E N/M
Unified AI Score
49.5 / 100 HOLD
Tech 57.0 Fund 56.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VTAK -94.28% TVGN +1198.42% Spread: +1564.7 pp (TVGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VTAK TTM Op. Margin: -388.1% TVGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTAK vs TVGN. Trailing 12-month operating profitability (VTAK -388.1% vs TVGN 0.0%) and valuation multiples (VTAK N/M vs TVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VTAK (2) vs TVGN (5)
Institutional Metric VTAK TVGN Criterion Row Winner
Market Capitalization Scale $548,639 $406.6M Larger Scale TVGN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +380.7% +0.0% Higher Growth VTAK
Operating Margin (TTM) Profitability -388.1% 0.0% Higher Margin TVGN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -111.3% 0.0% Higher ROE TVGN
52-Week Range Position Momentum 1% ($0โ€“$3) 47% ($0โ€“$12) Stronger Trend TVGN
Beta / 30D Volatility Risk Regime 0.19ฮฒ ยท 76% Vol 1.56ฮฒ ยท 62% Vol Lower Realized Risk TVGN
Unified Institutional Score Composite Signal 58.1 / 100 (HOLD) 49.5 / 100 (HOLD) Higher Composite VTAK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VTAK vs TVGN Buy Guide
VTAK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VTAK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TVGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TVGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VTAK nor TVGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.